cetylpyridinium chloride anhydrous has been researched along with Tuberculosis, Multidrug-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langendam, MW; Sandgren, A; Tiemersma, EW; van der Werf, MJ | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.
Topics: Antitubercular Agents; Bias; Contact Tracing; Health; Humans; Risk Factors; Tuberculosis, Multidrug-Resistant | 2013 |